Advertisement
Canada markets closed

  • S&P/TSX

    22,290.62
    +31.15 (+0.14%)
     

  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • CAD/USD

    0.7282
    -0.0004 (-0.06%)
     

  • CRUDE OIL

    78.37
    -0.01 (-0.01%)
     

  • Bitcoin CAD

    85,802.23
    -1,228.05 (-1.41%)
     

  • CMC Crypto 200

    1,304.48
    -60.64 (-4.44%)
     

  • GOLD FUTURES

    2,322.50
    -1.70 (-0.07%)
     

  • RUSSELL 2000

    2,064.65
    +3.97 (+0.19%)
     

  • 10-Yr Bond

    4.4630
    -0.0260 (-0.58%)
     

  • NASDAQ futures

    18,203.50
    +4.00 (+0.02%)
     

  • VOLATILITY

    13.23
    -0.26 (-1.93%)
     

  • FTSE

    8,313.67
    +100.18 (+1.22%)
     

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • CAD/EUR

    0.6771
    0.0000 (0.00%)
     

Lansdowne's Roden says likes animal genetics company Genus

Reuters

TEL AVIV (Reuters) - UK hedge fund Lansdowne Partners Chairman Stuart Roden said on Wednesday he recommended investing in British animal genetics improvements firm Genus Plc . "We love companies where the buyer of the product is enhancing their own productivity," he told the Sohn Conference in Tel Aviv. He said Genus spends 10 percent of sales on research and development and is a leader in its field. (Reporting by Steven Scheer and Tova Cohen)